Gilead Sciences Inc.
Gilead Sciences Inc. (GILD) — Form 144: Proposed sale of shares
AI-generated summary
Officer KEELEY M CAIN WETTAN of Gilead Sciences Inc. proposed to sell 3,399 shares of Common stock with an aggregate market value of $569,570.43 through Morgan Stanley Smith Barney LLC Executive Financial Services on November 6, 2026. The shares were originally acquired through the vesting of restricted stock units on August 10, 2026. The proposed sale was made under a trading plan adopted on August 7, 2026.
Key facts
- Seller
- KEELEY M CAIN WETTAN
- Relationship
- Officer
- Shares to sell
- 3,399
- Market value
- $569,570.43
- Approximate sale date
- Nov 6, 2026
- Broker
- Morgan Stanley Smith Barney LLC Executive Financial Services
- Acquired
- Aug 10, 2026 · Restricted Stock Units
Rule 10b5-1 plan · adopted Aug 7, 2026
Remarks
- The securities to be sold were acquired upon the vesting of restricted stock units during the period of 08/10/2026 through 09/10/2026.
More GILD filings
- 4
Filed Nov 6, 2026
- 144
Filed Nov 4, 2026
- 4
Filed Nov 2, 2026
- 144
Filed Oct 30, 2026
- 10-Q
Filed Oct 29, 2026
- 8-K
Filed Oct 29, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.